Metabolic flux analysis: A powerful tool for monitoring tissue function

Tissue Engineering

Volumn 5, Issue 4, 1999, Pages 347-368

  Lee, Kyongbum ^a,b   Berthiaume, Francois ^a   Stephanopoulos, Gregory N ^b   Yarmush, Martin L ^a,c  

^a SHRINERS HOSPITALS FOR CHILDREN   (United States)

^b Massachusetts Institute of Technology Cambridge   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOTECHNOLOGY; CALCULATION; CELL METABOLISM; CELL VIABILITY; ENERGY METABOLISM; ENGINEERING; MONITORING; NONHUMAN; PRIORITY JOURNAL; REVIEW; STOICHIOMETRY;

ANIMALS; BIOMEDICAL ENGINEERING; CELL PHYSIOLOGY; CELL SURVIVAL; CELLS; HUMANS; KINETICS; METABOLISM; MODELS, BIOLOGICAL;

EID: 0032787428     PISSN: 10763279     EISSN: None     Source Type: Journal    
DOI: 10.1089/ten.1999.5.347     Document Type: Review

References (147)

1. Holms, W.H. The central metabolic pathways of Escherichia coli: Relationship between flux and control at a branch point, efficiency of conversion to biomass, and excretion of acetate. Curr. Top. Cell Regul. 28, 69, 1986.
2. Nielsen, J.H. Bioreaction Engineering Principles. New York: Plenum Press, 1994.
3. Vallino, J.J., and Stephanopoulos, G. Metabolic flux distribution in corynebacterium glutamicum during growth and lysine overproduction. Biotechnol. Bioeng. 41, 633, 1993.
4. Vallino, J.J., and Stephanopoulos, G. Carbon flux distribution at the glucose-6-phosphate branch point in corynebacterium glutamicum during lysine overproduction. Biotechnol. Prog. 10, 327, 1994.
5. Stephanopoulos, G., and Vallino, J.J. Network rigidity and metabolic engineering in metabolite overproduction. Science 252, 1675, 1991.
6. Joergensen, H., Nielsen, J., Villadsen, J., and Moellgaard, H. Metabolic flux distribution in Penicilium chrysogenum during fed-batch cultivations. Biotechnol. Bioeng. 46, 117, 1995.
7. Pons, A., Dussap, C.G., Pequignot, C., and Gros, J.B. Metabolic flux distribution in Corynebacterium melassecola. Biotechnol. Bioeng. 51, 177, 1996.
8. Sauer, U., Hatzimanikatis, V., Bailey, J.E., Hochuli, M., Szyperski, T., and Wuthrich, K. Metabolic fluxes in riboflavin-producing Bacillus subtilis. Nat. Biotechnol. 15,448, 1997.
9. Bailey, J.E. Toward a science of metabolic engineering. Science 252, 1668, 1991.
10. Cameron, D.C., and Chaplen, F.W. Developments in metabolic engineering. Curr. Opin. Biotechnol. 8, 175, 1997.
11. Yarmush, M.L., and Berthiaume, F. Metabolic engineering and human disease. Nat. Biotechnol. 15, 525, 1997.
12. Nerem, R.M. Tissue engineering in the USA. Med Biol Eng Comput 30, CE8, 1992.
13. Patrick, C.W., Mikos, A.G., and McIntire, L.V., eds. Frontiers in Tissue Engineering. 1st ed. Pergamon: Oxford, U.K.; New York, NY, 1998.
14. Sahhar, A., Reuvney, S., David, Y., Budu, C., and Shainberg, A. Cerebral neurons, skeletal myoblasts, and cardiac muscle cells cultured on macroporous beads. Biotechnol. Bioeng. 43, 826, 1994.
15. Naughton, B.A., San Roman, J., Sibanda, B., Weintraub, J.P., and Kamali, V. Stereotypic culture systems for liver and bone marrow: Evidence for the development of functional fissue in vitro and following implantation in vivo. Biotechnol. Bioeng. 43, 810, 1994.
16. Tziampazis, E., and Sambanis, A. Tissue engineering of a bioartificial pancreas: Modeling the cell environment and device function. Biotechnol. Prog. 11, 115, 1995.
17. Cieslinski, D.A., and Humes, H.D. Tissue engineering of a bioartificial kidney. Biotechnol. Bioeng. 43, 678, 1994.
18. Foy, B.D., Toner, M., Tompkins, R.G., and Yarmush, M.L. Engineering organ perfusion protocols: NMR analysis of hepatocyte isolation from perfused rat liver. Biotechnol. Bioeng. 43, 661, 1994.
19. Stephanopoulos, G., and Sinskey, A.J. Metabolic engineering-Methodologies and future prospects. Trends. Biotechnol. 11, 392, 1993.
20. Fussenegger, M., Schlatter, S., Datwyler, D., Mazur, X., and Bailey, J.E. Controlled proliferation by multigene metabolic engineering enhances the productivity of Chinese hamster ovary cells [In Process Citation]. Nat. Biotechnol. 16, 468, 1998.
21. Naik, S., Trenkler, D., Santangini, H., Pan, J., and Jauregui, H.O. Isolation and culture of porcine hepatocytes for artificial liver support. Cell Transplant. 5, 107, 1996.
22. Boyce, S.T., Supp, A.P., Harriger, M.D., Greenhalgh, D.G., and Warden, G.D. Topical nutrients promote engraftment and inhibit wound contraction of cultured skin substitutes in athymic mice. J. Invest. Dermatol. 104, 345, 1995.
23. Naughton, G., Mansbridge, J., and Gentzkow, G. A metabolically active human derman replacement for the treatment of diabetic foot ulcers. Artif. Organs. 21, 1203, 1997.
24. Pincus, D.W., Goodman, R.R., Fraser, R.A., Nedergaard, M., and Goldman, S.A. Neural stem and progenitor cells: a strategy for gene therapy and brain repair. Neurosurgery 42, 858, 1998.
25. Xie, L., and Wang, D.I.C. High cell density and high monoclonal antibody production through medium design and rational control in a bioreactor. Biotechnol. Bioeng. 51, 725, 1996.
26. Minuth, W.W., Sittinger, M., and Kloth, S. Tissue engineering: generation of differentiated artificial tissues for biomedical applications. Cell Tissue Res. 291, 1, 1998.
27. Stryer, L. Biochemistry. New York: W.H. Freeman, 1995.
28. Bonarius, H.P.J., Hatzimanikatis, V., Meesters, K.P.H., de Gooijer, C.D., Schmid, G., and Tramper, J. Metabolic flux analysis of hybridoma cells in culture media using mass balances. Biotechnol. Bioeng. 50, 299, 1996.
29. Des Rosiers, C., Di Donato, L., Comte, B., et al. Isotopomer analysis of citric acid cycle and gluconeogenesis in rat liver. Reversibility of isocitrate dehydrogenase and involvement of ATP-citrate lyase in gluconeogenesis. J. Biol. Chem. 270, 10027, 1995.
30. Small, J.R., and Kacser, H. Responses of metabolic systems to large changes in enzyme activities and effectors. 1. The linear treatment of unbranched chains. Eur. J. Biochem. 213, 613, 1993.
31. Reich, J.G. Energy Metabolism of the Cell: A Theoretical Treatise. London: Academic Press, 1981.
32. Fell, D.A. Metabolic control analysis: A survey of its theoretical and experimental development. Biochem. J. 286, 313, 1992.
33. Varma, A., and Palsson, B.O. Metabolic flux balancing: Basic concepts, scientific, and practical use. Biotechnology 12, 994, 1994.
34. Strang, G. Introduction to Applied Mathematics. Wellesley, MA: Wellesley-Cambridge Press, 1986.
35. Romagnoli, J.A., and Stephanopoulos, G. Rectification of process measurement data in the presence of gross errors. Chem. Eng. Sci. 36, 1849, 1984.
36. Wang, N.S., and Stephanopoulos, G. Application of macroscopic balances to the identification of gross measurement errors. Biotechnol. Bioeng. 25, 2177, 1983.
37. Savinell, J.M., and Palsson, B.O. Network analysis of intermediary metabolism using linear optimization. II. Interpretation of hybridoma cell metabolism. J. Theor. Biol. 154, 455, 1992.
38. Savinell, J.M., and Palsson, B.O. Network analysis of intermediary metabolism using linear optimization. I. Development of mathematical formalism. J. Theor. Biol. 154, 421, 1992.
39. Bertsimas, D., and Tsitsiklis, J.N. Introduction to Linear Optimization. Athena Scientific Series in Optimization and Neural Computation. Belmont, MA: Athena Scientific, 1997.
40. Bonarius, H.P.J., Schmid, G., and Tramper, J. Flux analysis of underdetermined metabolic networks: the quest for the missing constraints. Trends. Biotechnol. 15, 308, 1997.
41. Weinman, E.O., Strisower, E.H., and Chaikoff, I.L. Conversion of fatty acids to carbohydrate. Applications of isotopes to this problem and the role of the Krebs cycle as a synthetic pathway. Physiol. Rev. 37, 252, 1957.
42. Rognstad, R., and Katz, J. Gluconeogenesis in the kidney cortex. Quantitative estimation of carbon flow. J. Biol. Chem. 247, 6047, 1972.
43. 14C]citrate specific activity ratios. Am. J. Physiol. 248, E252, 1985.
44. 2 ratios method for detecting pyruvate carboxylation. Anal. Biochem. 151, 55, 1985.
45. Cohen, D.M., and Bergman, R.N. SYNTAX: A rule-based stochastic simulation of the time-varying concentrations of positional isotopomers of metabolic intermediates. Comput. Biomed. Res. 27, 130, 1994.
46. Cohen, D.M., and Bergman, R.N. Prediction of positional isotopomers of the citric acid cycle: the syntactic approach. Am. J. Physiol. 266, E341, 1994.
47. Cohen, D.M., and Bergman, R.N. Estimation of TCA cycle flux, aminotransferase flux, and anaplerosis in heart: Validation with syntactic model. Am. J. Physiol. 268, E397, 1995.
48. 13C NMR studies in perfused rat hearts. J. Biol. Chem. 258, 13785, 1983.
49. 13C NMR spectroscopy and nonlinear least squares analysis. J. Biol. Chem. 270, 7999, 1995.
50. Yu, X., White, L.T., Doumen, C., et al. Kinetic analysis of dynamic.13C NMR spectra: Metabolic flux, regulation, and compartmentation in hearts. Biophys. J. 69, 2090, 1995.
51. Yu, X., White, L.T., Alpert, N.M., and Lewandowski, E.D. Subcellular metabolite transport and carbon isotope kinetics in the intramyocardial glutamate pool. Biochemistry 35, 6963, 1996.
52. Yu, X., Alpert, N.M., and Lewandowski, E.D. Modeling enrichment kinetics from dynamic 13C-NMR spectra: theoretical analysis and practical considerations. Am. J. Physiol. 272, C2037, 1997.
53. Park, S.M., Sinksey, A.J., and Stephanopoulos, G. Metabolic and physiological studies of Corynebacterium glutamicum mutants. Biotechnol. Bioeng. 55, 864, 1997.
54. 13C-NMR spectroscopy and GC-MS. Appl. Microbiol. Biotechnol. 47, 430, 1997.
55. Zupke, C., Tompkins, R., Yarmush, D., and Yarmush, M. Numerical isotopomer analysis: estimation of metabolic activity. Anal. Biochem. 247, 287, 1997.
56. Zupke, C. and Stephanopoulos, G. Modeling of isotope distributions and intracellular fluxes in metabolic networks using atom mapping matrices. Biotechnol. Prog. 10, 489, 1994.
57. 13C]glutamate isotopomer measurements. Am. J. Physiol. 266, E1012, 1994.
58. 13C mass isotopomer distribution analysis of intermediates. J. Biol. Chem. 270, 10037, 1995.
59. Schmidt, K., Carlsen, M., Nielsen, J., and Villadsen, J. Modeling isotopomer distributions in biochemical networks using isotopomer mapping matrices. Biotechnol. Bioeng. 55, 831, 1997.
60. Dolezal, J., and Fidler, J. System modeling and optimization: proceedings of the seventeenth IFIP TC7 conference on system modeling and optimization. In: IFIP Conference on System Modeling and Optimization. London: Chapman and Hall, 128-135, 1996.
61. Wiechert, W., and de Graaf, A.A. In vivo stationary flux analysis by 13C labeling. Adv. Biochem. Eng. Biotechnol. 54, 109, 1996.
62. Wiechert, W. and de Graaf, A.A. Bidirectional reaction steps in metabolic networks I. Biotechnol. Bioeng. 55, 101, 1997.
63. Reder, C. Metabolic control theory - A structural approach. J. Theor. Biol. 135, 175, 1988.
64. Wolfe, R.R. Tracers in Metabolic Research: Radioisotope and Stable Isotope/Mass Spectrometric Analysis. New York: A.R. Liss, 1984.
65. Wolfe, R.R. Radioactive and Stable Isotope Tracers in Biomedicine: Principles and Practice of Kinetic Analysis. New York: Wiley-Liss, 1992.
66. Hellerstein, M.K., Neese, R.A., Schwarz, J.M., Turner, S., Faix, D., and Wu, K. Altered fluxes responsible for reduced hepatic glucose production and gluconeogenesis by exogenous glucose in rats. Am. J. Physiol. 272, E163, 1997.
67. 13C-labeled substrates. FEBS Lett. 213, 209, 1987.
68. 13C)glucose. Biomed. Environ. Mass. Spectrom. 16, 305, 1988.
69. 13C]glucose. Proc. Natl. Acad. Sci. USA 86, 4690, 1989.
70. Kalderon, B., Korman, S.H., Gutman, A., and Lapidot, A. Glucose recycling and production in glycogenosis type I and III: stable isotope technique study. Am. J. Physiol. 257, E346, 1989.
71. Strong, J.M., Upton, D.K., Anderson, L.W., Monks, A., Chisena, C.A., and Cysyk, R.L. A novel approach to the analysis of mass spectrally assayed stable isotope-labeling experiments. J. Biol. Chem. 260, 4276, 1985.
72. Hellerstein, M.K., Kletke, C., Kaempfer, S., Wu, K., and Shackleton, C.H. Use of mass isotopomer distributions in secreted lipids to sample lipogenic acetyl-CoA pool in vivo in humans. Am. J. Physiol. 261, E479, 1991.
73. Hellerstein, M.K. Relationship between precursor enrichment and ratio of excess M2/excess Ml isotopomer frequencies in a secreted polymer. J. Biol. Chem. 266, 10920, 1991.
74. Hellerstein, M.K., Christiansen, M., Kaempfer, S., et al. Measurement of de novo hepatic lipogenesis in humans using stable isotopes. J. Clin. Invest. 87, 1841, 1991.
75. Hellerstein, M.K., and Neese, R.A. Mass isotopomer distribution analysis: A technique for measuring biosynthesis and turnover of polymers. Am. J. Physiol. 263, E988, 1992.
76. 2O and mass isotopomer analysis. Am. J. Physiol. 266, E699, 1994.
77. Lee, W.N., Bassilian, S., Guo, Z., Schoeller, D., Edmond, J., Bergner, E.A., and Byerley, L.O. Measurement of fractional lipid synthesis using deuterated water (2H2O) and mass isotopomer analysis. Am. J. Physiol. 266, E372, 1994.
78. Zilversmit, D.B., Entenman, C., and Fishier, M. The calculation of turnover rate and turnover time from experiments involving the use of labeling agents. J. Gen. Physiol. 26, 325, 1943.
79. Magnusson, I., Schumann, W.C., Bartsch, G.E., et al. Noninvasive tracing of Krebs cycle metabolism in liver. J. Biol. Chem. 266, 6975, 1991.
80. Landau, B.R. Estimating gluconeogenic rates in NIDDM. Adv. Exp. Med. Biol. 334, 209, 1993.
81. Neese, R.A., Schwarz, J.M., Faix, D., et al. Gluconeogenesis and intrahepatic triose phosphate flux in response to fasting or substrate loads. Application of the mass isotopomer distribution analysis technique with testing of assumptions and potential problems. J. Biol. Chem. 270, 14452, 1995.
82. Previs, S.F., Fernandez, C.A., Yang, D., Soloviev, M.V., David, F., and Brunengraber, H. Limitations of the mass isotopomer distribution analysis of glucose to study gluconeogenesis. Substrate cycling between glycerol and triose phosphates in liver. J. Biol. Chem. 270, 19806, 1995.
83. Kharroubi, A.T., Masterson, T.M., Aldaghlas, T.A., Kennedy, K.A., and Kelleher, J.K. Isotopomer spectral analysis of triglyceride fatty acid synthesis in 3T3-L1 cells. Am. J. Physiol. 263, E667, 1992.
84. Kelleher, J.K., Kharroubi, A.T., Aldaghlas, T.A., et al. Isotopomer spectral analysis of cholesterol synthesis: applications in human hepatoma cells. Am. J. Physiol. 266, E384, 1994.
85. 14C isotopic techniques. Am. J. Physiol. 272, E945, 1997.
86. Lligona-Trulla, L., Arduini, A., Aldaghlas, T.A., Calvani, M., and Kelleher, J.K. Acetyl-L-carnitine flux to lipids in cells estimated using isotopomer spectral analysis. J. Lipid Res. 38, 1454, 1997.
87. Crawford, J.M., and Blum, J.J. Quantitative analysis of flux along the gluconeogenic, glycolytic and pentose phosphate pathways under reducing conditions in hepatocytes isolated from fed rats. Biochem. J. 212, 585, 1983.
88. Sharfstein, S.T., Tucker, S.N., Mancuso, A., Blanch, H.W., and Clark, D.S. Quantitative in vivo nuclear magnetic resonance studies of hybridoma metabolism. Biotechnol. Bioeng. 43, 1059, 1994.
89. Zupke, C., Sinskey, A.J., and Stephanopoulos, G. Intracellular flux analysis applied to the effect of dissolved oxygen on hybridomas. Appl. Microbiol. Biotechnol. 44, 27, 1995.
90. Marx, A., de Graaf, A.A., Wiechert, W., Eggeling, L., and Sahm, H. Determination of the fluxes in the central metabolism of Corynebacterium glutamicum by nuclear magnetic resonance spectroscopy combined with metabolite balancing. Biotechnol. Bioeng. 49, 111, 1996.
91. Wiechert, W., Siefke, C., de Graaf, A.A., and Marx, A. Bidirectional reaction steps in metabolic networks II. Biotechnol. Bioeng. 55, 118, 1997.
92. 13C]homonuclear decoupling. Magn. Reson. Med. 31, 374, 1994.
93. Patterson, B.W., Zhang, X.J., Chen, Y., Klein, S., and Wolfe, R.R. Measurement of very low stable isotope enrichments by gas chromatography/mass spectrometry: Application to measurement of muscle protein synthesis. Metabolism 46, 943, 1997.
94. Eisenreich, W., Strauss, G., Werz, U., Fuchs, G., and Bacher, A. Retrobiosynthetic analysis of carbon fixation in the phototrophic eubacterium Chloroflexus aurantiacus. Eur. J. Biochem. 215, 619, 1993.
95. 13C-labeling of proteinogenic amino acids. An efficient analytical tool to investigate intermediary metabolism. Eur. J. Biochem. 232, 433, 1995.
96. 13C nuclear magnetic resonance. J. Bacteriol. 156, 316, 1983.
97. 2 fixation pathways in the sulfur-reducing Archaebacterium Thermoproteus neutrophilus and in the phototrophic Eubacterium Chloroflexus aurantiacus. Eur. J. Biochem. 205, 853, 1992.
98. Wykes, L.J., Jahoor, F., and Reeds, P.J. Gluconeogenesis measured with [U-13C]glucose and mass isotopomer analysis of apoB-100 amino acids in pigs. Am. J. Physiol. 274, E365, 1998.
99. Follstad, B.D., and Stephanopoulos, G. Effect of reversible reactions on isotope label redistribution - Analysis of the pentose phosphate pathway. Eur. J. Biochem. 252, 360, 1998.
100. Savinell, J.M., and Palsson, B.O. Optimal selection of metabolic fluxes for in vivo measurement. II. Application to Escherichia coli and hybridoma cell metabolism. J. Theor. Biol. 155, 215, 1992.
101. Savinell, J.M., and Palsson, B.O. Optimal selection of metabolic fluxes for in vivo measurement. I. Development of mathematical methods. J. Theor. Biol. 155, 201, 1992.
102. 6]glucose. Am. J. Physiol. 259, E757, 1990.
103. Malloy, C.R., Sherry, A.D., and Jeffrey, F.M. Analysis of tricarboxylic acid cycle of the heart using 13C isotope isomers. Am. J. Physiol. 259, H987, 1990.
104. 13C NMR spectroscopy. J. Biol. Chem. 263, 6964, 1988.
105. 13C]glutamate isotopomers in liver. Am. J. Physiol. 272, C2049, 1997.
106. 13C]glucose in rats. J. Biol. Chem. 264, 12994, 1989.
107. Katz, J., and Lee, W.N. Application of mass isotopomer analysis for determination of pathways of glycogen synthesis. Am. J. Physiol. 261, E332, 1991.
108. 13C]glucose [published erratum appears in Proc. Natl. Acad. Sci. USA 88, 5477, 1991]. Proc. Natl. Acad. Sci. USA 88, 2103, 1991.
109. Bachelard, H.S., Brooks, K.J., and Garofalo, O. Studies on the compartmentation of DOG metabolism in the brain. Neurochem. Res. 16, 1025, 1991.
110. Badar-Goffer, R.S., Ben-Yoseph, O., Bachelard, H.S., and Morris, P.O. Neuronal-glial metabolism under depolarizing conditions. A 13C-n.m.r. study. Biochem. J. 282, 225, 1992.
111. 13CN.M.R. spectroscopy. A technique for investigating metabolic compartmentation in the brain. Biochem. J. 266, 133, 1990.
112. Brand, A., Richter-Landsberg, C., and Leibriftz, D. Metabolism of acetate in rat brain neurons, astrocytes and cocultures: Metabolic interactions between neurons and glia cells, monitored by NMR spectroscopy. Cell. Mol. Biol. 43, 645, 1997.
113. Lee, W.N., Edmond, J., Bassilian, S., and Morrow, J.W. Mass isotopomer study of glutamine oxidation and synthesis in primary culture of astrocytes. Dev. Neurosci. 18, 469, 1996.
114. Lin, Y.Y., Cheng, W.B., and Wright, C.E. Glucose metabolism in mammalian cells as determined by mass isotopomer analysis. Anal. Biochem. 209, 267, 1993.
115. Portais, J.C., Voisin, P., Merle, M., and Canioni, P. Glucose and glutamine metabolism in C6 glioma cells studied by carbon 13 NMR. Biochimie 78, 155, 1996.
116. Sonnewald, U., White, L.R., Odegard, E., et al. MRS study of glutamate metabolism in cultured neurons/glia. Neurochem. Res. 21, 987, 1996.
117. Baranyai, J.M., and Blum, J.J. Quantitative analysis of intermediary metabolism in rat hepatocytes incubated in the presence and absence of ethanol with a substrate mixture including ketoleucine. Biochem. J. 258, 121, 1989.
118. Rabkin, M., and Blum, J.J. Quantitative analysis of intermediary metabolism in hepatocytes incubated in the presence and absence of glucagon with a substrate mixture containing glucose, ribose, fructose, alanine and acetate. Biochem. J. 225, 761, 1985.
119. Lee, W.N., Byerley, L.O., Bassilian, S., et al. Isotopomer study of lipogenesis in human hepatoma cells in culture: Contribution of carbon and hydrogen atoms from glucose. Anal. Biochem. 226, 100, 1995.
120. Lee, W.N., Boros, L.G., Puigjaner, J., Bassilian, S., Lim, S., and Cascante, M. Mass isotopomer study of the nonoxidative pathways of the pentose cycle with [1,2-13C2]glucose. Am. J. Physiol. 274, E843, 1998.
121. Holleran, A.L., Briscoe, D.A., Fiskum, G., and Kelleher, J.K. Glutamine metabolism in AS-30D hepatoma cells. Evidence for its conversion into lipids via reductive carboxylation. Mol. Cell. Biochem. 152, 95, 1995.
122. Zupke, C., and Stephanopoulos, G. Intracellular flux analysis in hybridomas using mass balances and in vitro 13C NMR. Biotechnol. Bioeng. 45, 292, 1995.
123. Lewandowski, E.D., Damico, L.A., White, L.T., and Yu, X. Cardiac responses to induced lactate oxidation: NMR analysis of metabolic equilibria. Am. J. Physiol. 269, H160, 1995.
124. Lewandowski, E.D., Doumen, C., White, L.T., LaNoue, K.F., Damico, L.A., and Yu, X. Multiplet structure of 13C NMR signal from glutamate and direct detection of tricarboxylic acid (TCA) cycle intermediates. Magn. Reson. Med. 35, 149, 1996.
125. Lewandowski, E.D., Yu, X., LaNoue, K.F., White, L.T., Doumen, C., and O'Donnell, J.M. Altered metabolite exchange between subcellular compartments in intact postischemic rabbit hearts. Circ. Res. 81, 165, 1997.
126. 13C NMR. Am. J. Physiol. 273, E1228, 1997.
127. 13C labeling of citrate released by perfused rat hearts. J. Biol. Chem. 272, 26117, 1997.
128. 13C isotopomer n.m.r. method for monitoring incomplete beta-oxidation of fatty acids in intact tissue. Biochem. J. 303, 847, 1994.
129. Jeffrey, F.M., Diczku, V., Sherry, A.D., and Malloy, C.R. Substrate selection in the isolated working rat heart: effects of reperfusion, afterload, and concentration. Basic. Res. Cardiol. 90, 388, 1995.
130. Jeffrey, F.M., Alvarez, L., Diczku, V., Sherry, A.D., and Malloy, C.R. Direct evidence that perhexiline modifies myocardial substrate utilization from fatty acids to lactate. J. Cardiovasc. Pharmacol. 25, 469, 1995.
131. 13C isotopomer model for estimation of anaplerotic substrate oxidation via acetyl-CoA. Am. J. Physiol. 271, E788, 1996.
132. Jessen, M.E., Kovarik, T.E., Jeffrey, P.M., et al. Effects of amino acids on substrate selection, anaplerosis, and left ventricular function in the ischemic reperfused rat heart. J. Clin. Invest. 92, 831, 1993.
133. Jones, J.G., Le, T.H., Storey, C.J., Sherry, A.D., Malloy, C.R., and Burton, K.P. Effects of different oxidative insults on intermediary metabolism in isolated perfused rat hearts. Free Radie. Biol. Med. 20, 515, 1996.
134. 13C mass isotopomer study. Am. J. Physiol. 272, E74, 1997.
135. 2 consumption in the heart. MAGMA 4, 35, 1996.
136. 13C N.M.R. spectroscopy. Biochem. J. 254, 593, 1988.
137. Solomon, M.A., Jeffrey, F.M., Storey, C.J., Sherry, A.D., and Malloy, G.R. Substrate selection early after reperfusion of ischemic regions in the working rabbit heart. Magn. Reson. Med. 35, 820, 1996.
138. 13C labeling pattern of glutamate. J. Biol. Chem. 268, 4170, 1993.
139. Large, V., Brunengraber, H., Odeon, M., and Beylot, M. Use of labeling pattern of liver glutamate to calculate rates of citric acid cycle and gluconeogenesis. Am. J. Physiol. 272, E51, 1997.
140. Beylot, M., Peroni, O., Diraison, P., and Large, V. New methods for in vivo studies of hepatic metabolism. Reprod. Nutr. Dev. 36, 363, 1996.
141. Beylot, M., Peroni, O., Diraison, F., and Large, V. In vivo studies of intrahepatic metabolic pathways. Diabetes Metab. 23, 251, 1997.
142. 13C]fructose. Proc. Natl. Acad. Sci. USA 87, 5449, 1990.
143. Hellerstein, M.K., Neese, R.A., Linfoot, P., Christiansen, M., Turner, S., and Letscher, A. Hepatic gluconeogenic fluxes and glycogen turnover during fasting in humans. A stable isotope study. J. Clin. Invest. 100, 1305, 1997.
144. Hellerstein, M.K., Neese, R.A., Letscher, A., Linfoot, P., and Turner, S. Hepatic glucose-6-phosphatase flux and glucose phosphorylation, cycling, irreversible disposal, and net balance in vivo in rats. Measurement using the secreted glucuronate technique. Metabolism 46, 1390, 1997.
145. Katz, J., Wals, P., and Lee, W.N. Isotopomer studies of gluconeogenesis and the Krebs cycle with 13C-labeled lactate. J. Biol. Chem. 268, 25509, 1993.
146. 13C]glucose study. Am. J. Physiol. 270, E709, 1996.
147. 13C NMR measurements of hepatocellular tricarboxylic acid cycle flux. J. Biol. Chem. 273, 12187, 1998.